[HTML][HTML] Pathophysiology and treatment of stroke: present status and future perspectives

D Kuriakose, Z Xiao - International journal of molecular sciences, 2020 - mdpi.com
Stroke is the second leading cause of death and a major contributor to disability worldwide.
The prevalence of stroke is highest in developing countries, with ischemic stroke being the …

[HTML][HTML] Immune cells in the BBB disruption after acute ischemic stroke: targets for immune therapy?

Y Qiu, C Zhang, A Chen, H Wang, Y Zhou… - Frontiers in …, 2021 - frontiersin.org
Blood-Brain Barrier (BBB) disruption is an important pathophysiological process of acute
ischemic stroke (AIS), resulting in devastating malignant brain edema and hemorrhagic …

Honokiol: A review of its pharmacological potential and therapeutic insights

A Rauf, A Olatunde, M Imran, FA Alhumaydhi… - Phytomedicine, 2021 - Elsevier
Background Honokiol is a pleiotropic compound which been isolated from Magnolia species
such as Magnolia grandiflora and Magnolia dealbata. Magnolia species Magnolia …

[HTML][HTML] The mechanism of microglia-mediated immune inflammation in ischemic stroke and the role of natural botanical components in regulating microglia: A review

J Zeng, T Bao, K Yang, X Zhu, S Wang… - Frontiers in …, 2023 - frontiersin.org
Ischemic stroke (IS) is one of the most fatal diseases. Neuroimmunity, inflammation, and
oxidative stress play important roles in various complex mechanisms of IS. In particular, the …

Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets

K Banik, AM Ranaware, V Deshpande… - Pharmacological …, 2019 - Elsevier
In spite of billions of dollars expended on cancer research every year, the incidence rate and
the mortality rate due to this widespread disease has increased drastically over the last few …

[HTML][HTML] Ameliorating effects of traditional Chinese medicine preparation, Chinese materia medica and active compounds on ischemia/reperfusion-induced cerebral …

K Sun, J Fan, J Han - Acta Pharmaceutica Sinica B, 2015 - Elsevier
Ischemic stroke and ischemia/reperfusion (I/R) injury induced by thrombolytic therapy are
conditions with high mortality and serious long-term physical and cognitive disabilities. They …

[HTML][HTML] Phyto-therapeutic and nanomedicinal approaches to cure Alzheimer's disease: present status and future opportunities

M Ovais, N Zia, I Ahmad, AT Khalil, A Raza… - Frontiers in aging …, 2018 - frontiersin.org
Alzheimer's disease (AD) is characterized by cognitive inability manifested due to the
accumulation of β-amyloid, formation of hyper phosphorylated neurofibrillary tangles, and a …

Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease

AK Sahoo, J Dandapat, UC Dash, S Kanhar - Journal of …, 2018 - Elsevier
Ethnopharmacological relevance Alzheimer's disease (AD), a deleterious
neurodegenerative disorder that impairs memory, cognitive functions and may lead to …

[HTML][HTML] Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents

M Poivre, P Duez - Journal of Zhejiang University. Science. B, 2017 - ncbi.nlm.nih.gov
Traditional Chinese herbal drugs have been used for thousands of years in Chinese
pharmacopoeia. The bark of Magnolia officinalis Rehder & E. Wilson, known under the …

Neuroprotection in stroke: past, present, and future

A Majid - International Scholarly Research Notices, 2014 - Wiley Online Library
Stroke is a devastating medical condition, killing millions of people each year and causing
serious injury to many more. Despite advances in treatment, there is still little that can be …